3J5M image
Deposition Date 2013-10-26
Release Date 2013-11-13
Last Version Date 2024-11-27
Entry Detail
PDB ID:
3J5M
Title:
Cryo-EM structure of the BG505 SOSIP.664 HIV-1 Env trimer with 3 PGV04 Fabs
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
5.80 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:BG505 SOSIP gp120
Gene (Uniprot):env
Mutagens:T332N,A501C
Chain IDs:A, E, I
Chain Length:475
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:BG505 SOSIP gp41
Chain IDs:B, F, J
Chain Length:64
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:PGV04 light chain
Chain IDs:C, G, K
Chain Length:208
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:PGV04 heavy chain
Chain IDs:D, H, L
Chain Length:228
Number of Molecules:3
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer.
Science 342 1484 1490 (2013)
PMID: 24179160 DOI: 10.1126/science.1245627

Abstact

The HIV-1 envelope glycoprotein (Env) trimer contains the receptor binding sites and membrane fusion machinery that introduce the viral genome into the host cell. As the only target for broadly neutralizing antibodies (bnAbs), Env is a focus for rational vaccine design. We present a cryo-electron microscopy reconstruction and structural model of a cleaved, soluble Env trimer (termed BG505 SOSIP.664 gp140) in complex with a CD4 binding site (CD4bs) bnAb, PGV04, at 5.8 angstrom resolution. The structure reveals the spatial arrangement of Env components, including the V1/V2, V3, HR1, and HR2 domains, as well as shielding glycans. The structure also provides insights into trimer assembly, gp120-gp41 interactions, and the CD4bs epitope cluster for bnAbs, which covers a more extensive area and defines a more complex site of vulnerability than previously described.

Legend

Protein

Chemical

Disease

Primary Citation of related structures